{"id":66228,"date":"2019-12-30T23:55:42","date_gmt":"2019-12-31T04:55:42","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/a-fda-concedeu-a-designacao-de-avanco\/"},"modified":"2019-12-30T23:55:42","modified_gmt":"2019-12-31T04:55:42","slug":"a-fda-concedeu-a-designacao-de-avanco","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/pt-br\/a-fda-concedeu-a-designacao-de-avanco\/","title":{"rendered":"A FDA concedeu a designa\u00e7\u00e3o de avan\u00e7o"},"content":{"rendered":"<p>A Administra\u00e7\u00e3o de Alimentos e Medicamentos dos EUA concedeu uma Designa\u00e7\u00e3o de Terapia Inovadora ao cobimetinibe para o tratamento de pacientes com neoplasias histioc\u00edticas (Erdheim-Chester Doen\u00e7a de Langerhans, Rosai-Dorfman, Histiocitose de Langerhans), que n\u00e3o apresentam a muta\u00e7\u00e3o <em>BRAF<\/em> V600. Esse n\u00e3o \u00e9 apenas um grande avan\u00e7o para os pacientes <em>BRAF-negativos<\/em> ECD, mas para todas as histiocitoses. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Administra\u00e7\u00e3o de Alimentos e Medicamentos dos EUA concedeu uma Designa\u00e7\u00e3o de Terapia Inovadora ao cobimetinibe para o tratamento de pacientes com neoplasias histioc\u00edticas (Erdheim-Chester Doen\u00e7a de Langerhans, Rosai-Dorfman, Histiocitose [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":91090,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_wds_title":"","_wds_metadesc":"","_wds_focus-keywords":"","_wds_meta-robots-adv":"","_wds_meta-robots-noindex":false,"_wds_meta-robots-nofollow":false,"_wds_meta-robots-index":false,"_wds_meta-robots-follow":false,"_wds_autolinks-exclude":false,"_wds_canonical":"","_wds_redirect":"","_wds_opengraph":[],"_wds_twitter":[],"cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2085],"tags":[2120],"class_list":["post-66228","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicados-a-imprensa","tag-2019-pt-br"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/posts\/66228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/comments?post=66228"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/posts\/66228\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/media\/91090"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/media?parent=66228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/categories?post=66228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt-br\/wp-json\/wp\/v2\/tags?post=66228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}